Cibus Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Trading Arrangements
Adoptions
On March 28, 2024, Rory Riggs, the Company's Chairman and Chief Executive Officer, entered into a written plan for the sale of an aggregate of up to 300,000 shares of the Company's Class A Common Stock, which is scheduled to terminate no later than July 12, 2024.
On March 28, 2024, Peter Beetham, the Company's President and Chief Operating Officer and a member of the Company’s board of directors, as trustee for the Peter and Vanessa Beetham Trust U/A DTD July 22, 2010, entered into a written plan for the sale of an aggregate of up to 27,000 shares of the Company's Class A Common Stock, which is scheduled to terminate no later than October 2, 2024.
On March 27, 2024, Greg Gocal, the Company's Chief Scientific Officer and Executive Vice President, entered into a written plan for the sale of an aggregate of up to 30,000 shares of the Company's Class A Common Stock, which is scheduled to terminate no later than November 15, 2024.
Each of the plans described above are intended to satisfy affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
- 36 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.